Invasive Pneumococcal Disease Clinical Trial
Official title:
A Postmarketing Observational Study Estimating The Impact Of Prevnar 13 (Trade Mark) (13vpnc) On Invasive Pneumococcal Disease Caused By Vaccine Serotypes Of Streptococcus Pneumoniae After Introduction Into Routine Pediatric Use
This study will estimate the incidence of invasive pneumococcal disease in members of the Northern Kaiser Permanente healthcare system during each of the 5 following introduction of Prevnar 13.
No sampling as no subjects are enrolled ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00853749 -
Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine
|
Phase 3 | |
Completed |
NCT00227188 -
Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.
|
N/A | |
Recruiting |
NCT00885625 -
7-valent Pneumococcal Conjugated Vaccination
|
Phase 4 | |
Completed |
NCT04464291 -
An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years
|
N/A | |
Completed |
NCT01083459 -
Impact of PCV on Disease and Colonization Among Native American Communities
|
N/A | |
Completed |
NCT00371878 -
Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection
|
Phase 4 |